Moderna Appoints Juan Andres as Chief Operating Officer

What Happened
Moderna, Inc. filed an 8-K on September 30, 2026 announcing the appointment of Juan Andres as Chief Operating Officer, effective October 5, 2026. Mr. Andres, 62, previously held senior operations roles at Moderna (including Chief Technical Operations and Quality Officer, 2018–2022) and will report to CEO Stéphane Bancel and join the company’s Executive Committee. The company also announced that Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer, will retire.

Key Details

• Base salary: $800,000 per year (initial).
• Annual cash bonus: eligible, pro‑rated for 2026, with an incentive target equal to 90% of base salary; actual payment determined by the Compensation and Talent Committee.
• New-hire equity: $5,000,000 total value grant, subject to a four‑year vesting schedule; may be delivered as stock options and/or RSUs (no more than 75% of value as RSUs).
• Future equity: eligible for annual equity awards with a target value of $4,000,000–$5,000,000 (subject to committee adjustment).
• Other terms: participation in the executive severance plan, an indemnification agreement, and an employee confidentiality/assignment/nonsolicitation/noncompetition agreement. Offer letter dated September 3, 2026. A press release was furnished as Exhibit 99.1.

Why It Matters
This filing documents a senior leadership change and the associated compensation package. Investors should note the size and structure of Mr. Andres’ pay (meaningful base salary plus large equity awards and incentive targets), which reflects the company’s emphasis on experienced operational leadership as it scales and diversifies. The retirement of the prior Chief Technical Operations and Quality Officer is a material executive transition that could affect operational continuity; Moderna has disclosed succession and compensation terms but did not report any other material financial impacts in this 8‑K.